financetom
Business
financetom
/
Business
/
UBS Says Tariff News Could See US Dollar-Canadian Dollar Spike
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UBS Says Tariff News Could See US Dollar-Canadian Dollar Spike
Mar 28, 2025 5:15 AM

07:48 AM EDT, 03/28/2025 (MT Newswires) -- USDCAD has been moving closer to this year's lower bound, said UBS.

However, with recessionary risks looming large over the Canadian economy, the bank thinks the exchange rate trajectory is still likely to be upward in Q2. Survey data already point to weaker activity ahead on the consumer and business side.

As a consequence, UBS wouldn't be surprised if hard data soften further with the labor market readings next week potentially coming in on the disappointing side. With higher inflation than expected, there isn't much room to lower rates either beyond one or two more 25bps cuts, in the bank's view.

Such a stagflationary backdrop is rarely positive for a currency.

At this point, with tariffs front and center, the bank's bias is for USDCAD to soon rise into a 1.44-1.46 range, rather than step down meaningfully below 1.42 in the coming weeks.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
May 6, 2024
May 6 (Reuters) - Gossamer Bio ( GOSS ) said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and commercialize its therapy seralutinib in multiple indications related to high blood pressure due to constriction of lung arteries. The therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000...
Block Plans $1.5 Billion Senior Notes Offering
Block Plans $1.5 Billion Senior Notes Offering
May 6, 2024
08:18 AM EDT, 05/06/2024 (MT Newswires) -- Block (SQ) said Monday it plans a private placement of $1.5 billion in senior notes. The company and the purchasers have yet to set the interest rate, redemption provisions, maturity date, and other terms of the notes. Block intends to use the net proceeds from this offering for general corporate purposes, which may...
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial
May 6, 2024
08:16 AM EDT, 05/06/2024 (MT Newswires) -- Spectral Medical ( EDTXF ) , which is advancing therapeutic options for sepsis and septic shock, on Monday provided an update on its Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (PMX) in a trial of adults treated for endotoxemia and septic shock. The company reports that...
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
May 6, 2024
08:18 AM EDT, 05/06/2024 (MT Newswires) -- LSL Pharma Group ( LPGIF ) on Monday said it will acquire a rival pharmaceutical manufacturer for $2.5 million in cash to expand its contract-manufacturing of natural health products. LSL identified the company only as a Quebec-based competing contract drug manufacturer (CDMO) specialized in the formulation, production, and marketing of natural products. LSL...
Copyright 2023-2026 - www.financetom.com All Rights Reserved